Laura studied at the University of Bristol where she completed her degree in Pathology and Microbiology and later her PhD in Neuroscience. In 2004 she began a technical post with the South West Dementia Brain Bank (SWDBB) which she now manages

The Renin Angiotensin System and Alzheimer's disease

Robinson, AC, Palmer, L, Love, S, Hamard, M, Esiri, M, Ansorge, O, Lett, D, Attems, J, Morris, C, Troakes, C, Selvackadunco, S, King, A, Al-Sarraj, S & Mann, DMA, 2016, ‘Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK’. Acta Neuropathologica. Miners, JS, Palmer, JC, Tayler, H, Palmer, LE, Ashby, E, Kehoe, PG & Love, S, 2014, ‘Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes: Divergent effects of multifunctional enzymes’. Frontiers in aging neuroscience, vol 6., pp. 238 Baig, S, Palmer, L, Owen, M, Williams, J, Kehoe, P & Love, S, 2012, ‘Clusterin mRNA and protein in Alzheimer's disease’. Journal of Alzheimer's disease : JAD, vol 1;28(2)., pp. 337 - 344 Ferrington, L, Palmer, L, Love, S, Horsburgh, K, Kelly, P & Kehoe, PG, 2012, ‘Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse’. Am J Transl Res, vol 4., pp. 151 - 164 Ferrington, L, Miners, JS, Palmer, LE, Bond, SM, Povey, JE, Kelly, PAT, Love, S, Horsburgh, KJ & Kehoe, PG, 2011, ‘Angiotensin II-inhibiting drugs have no effect on intraneuronal aβ or oligomeric aβ levels in a triple transgenic mouse model of alzheimer's disease’. American Journal of Translational Research, vol 3., pp. 197-208 Culpan, D, Cram, D, Chalmers, KA, Cornish, A, Palmer, L, Palmer, J, Hughes, A, Passmore, P, Craig, D, Craigs, D, Wilcock, GK, Kehoe, PG & Love, S, 2009, ‘TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease’. Neurobiology of Aging, vol 30., pp. 1052 - 1060 Miners, JS, Baig, S, Palmer, J, Palmer, LE, Kehoe, PG & Love, S, 2008, ‘Abeta-degrading enzymes in Alzheimer's disease’. Brain Pathology, vol 18., pp. 240-52 Miners, J, Ashby, E, van Helmond, Z, Chalmers, K, Palmer, L, Love, S & Kehoe, P, 2007, ‘Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy’. Neuropathology and Applied Neurobiology, vol 34 ., pp. 181 - 193 Culpan, D, Prince, J, Matthews, S, Palmer, L, Hughes, A, Love, S, Kehoe, P & Wilcock, G, 2006, ‘Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease’. Neuroscience Letters, vol 408 (2)., pp. 141 - 145